Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Feb;79(5-6):940–944. doi: 10.1038/sj.bjc.6690150

Immunohistochemical localization of CD1a-positive putative dendritic cells in human breast tumours

E E Hillenbrand 1, A M Neville 1, B J Coventry 1
PMCID: PMC2362664  PMID: 10070894

Abstract

The presence of a high number of infiltrating CD1a+cells in malignant neoplasms has been reported to be associated with an improved prognosis, reduced tumour recurrence and fewer metastases. This study identified a population of CD1a+cells within the lymphoid cell infiltrate in human ductal breast carcinoma (n= 52), which was significantly different from normal breast tissue, in which only two out of nine cases expressed CD1a+cells (P= 0.0192). In the majority of cases, the infiltrate was low compared with the number of macrophages and T cells present (results not shown). There was no correlation between the number of CD1a+cells and tumour grade, with all tumour grades expressing similar numbers of infiltrating CD1a+cells. There was clear evidence, however, that the CD1a+cells were closely associated with tumour cells. It is likely that CD1a+cells have a role in antigen capture and presentation in human tumours, and this study documents the density of CD1a+cells in a large sample of all histological grades of human breast carcinomas. 1999 Cancer Research Campaign

Keywords: CD1a, dendritic cells, immunohistochemistry, breast, tumour, human, cancer

Full Text

The Full Text of this article is available as a PDF (323.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett A. W., Beynon A. D., Reid D. J. A comparative study on tissue processing procedures for the immunohistochemical investigation of oral mucosal Langerhans cells. Histochem J. 1994 Feb;26(2):134–141. doi: 10.1007/BF00157962. [DOI] [PubMed] [Google Scholar]
  2. Becker Y. Anticancer role of dendritic cells (DC) in human and experimental cancers--a review. Anticancer Res. 1992 Mar-Apr;12(2):511–520. [PubMed] [Google Scholar]
  3. Borgstein P. J., Meijer S., Pijpers R. Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet. 1997 Jun 7;349(9066):1668–1669. doi: 10.1016/s0140-6736(05)62634-7. [DOI] [PubMed] [Google Scholar]
  4. Chaux P., Hammann A., Martin F., Martin M. Surface phenotype and functions of tumor-infiltrating dendritic cells: CD8 expression by a cell subpopulation. Eur J Immunol. 1993 Oct;23(10):2517–2525. doi: 10.1002/eji.1830231021. [DOI] [PubMed] [Google Scholar]
  5. Coventry B. J., Austyn J. M., Chryssidis S., Hankins D., Harris A. Identification and isolation of CD1a positive putative tumour infiltrating dendritic cells in human breast cancer. Adv Exp Med Biol. 1997;417:571–577. doi: 10.1007/978-1-4757-9966-8_92. [DOI] [PubMed] [Google Scholar]
  6. Coventry B. J., Bradley J., Skinner J. M. Differences between standard and high-sensitivity immunohistology in tissue sections--comparison of immunoperoxidase staining methods using computerized video image analysis techniques. Pathology. 1995 Jul;27(3):221–223. doi: 10.1080/00313029500169013. [DOI] [PubMed] [Google Scholar]
  7. Coventry B. J., Neoh S. H., Mantzioris B. X., Skinner J. M., Zola H., Bradley J. A comparison of the sensitivity of immunoperoxidase staining methods with high-sensitivity fluorescence flow cytometry-antibody quantitation on the cell surface. J Histochem Cytochem. 1994 Aug;42(8):1143–1147. doi: 10.1177/42.8.8027533. [DOI] [PubMed] [Google Scholar]
  8. Coventry B. J., Weeks S. C., Heckford S. E., Sykes P. J., Bradley J., Skinner J. M. Lack of IL-2 cytokine expression despite Il-2 messenger RNA transcription in tumor-infiltrating lymphocytes in primary human breast carcinoma: selective expression of early activation markers. J Immunol. 1996 May 1;156(9):3486–3492. [PubMed] [Google Scholar]
  9. Dranoff G., Soiffer R., Lynch T., Mihm M., Jung K., Kolesar K., Liebster L., Lam P., Duda R., Mentzer S. A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor. Hum Gene Ther. 1997 Jan 1;8(1):111–123. doi: 10.1089/hum.1997.8.1-111. [DOI] [PubMed] [Google Scholar]
  10. Elsässer-Beile U., von Kleist S. Cytokines as therapeutic and diagnostic agents. Tumour Biol. 1993;14(2):69–94. doi: 10.1159/000217827. [DOI] [PubMed] [Google Scholar]
  11. Enk A. H., Jonuleit H., Saloga J., Knop J. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer. 1997 Nov 4;73(3):309–316. doi: 10.1002/(sici)1097-0215(19971104)73:3<309::aid-ijc1>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  12. Ferradini L., Mackensen A., Genevée C., Bosq J., Duvillard P., Avril M. F., Hercend T. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion. J Clin Invest. 1993 Mar;91(3):1183–1190. doi: 10.1172/JCI116278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Giuliano A. E., Jones R. C., Brennan M., Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997 Jun;15(6):2345–2350. doi: 10.1200/JCO.1997.15.6.2345. [DOI] [PubMed] [Google Scholar]
  14. Hanau D., Fricker D., Bieber T., Esposito-Farese M. E., Bausinger H., Cazenave J. P., Donato L., Tongio M. M., de la Salle H. CD1 expression is not affected by human peptide transporter deficiency. Hum Immunol. 1994 Sep;41(1):61–68. doi: 10.1016/0198-8859(94)90086-8. [DOI] [PubMed] [Google Scholar]
  15. Hart D. N. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood. 1997 Nov 1;90(9):3245–3287. [PubMed] [Google Scholar]
  16. Head J. F., Elliott R. L., McCoy J. L. Evaluation of lymphocyte immunity in breast cancer patients. Breast Cancer Res Treat. 1993;26(1):77–88. doi: 10.1007/BF00682702. [DOI] [PubMed] [Google Scholar]
  17. Huang J. A., Huang H. D., Peng Q. B., Zhu Z. J., Yu X. R. S100 protein-positive dendritic cells and the significance of their density in gastric precancerous lesions. Proc Chin Acad Med Sci Peking Union Med Coll. 1990;5(2):93–96. [PubMed] [Google Scholar]
  18. Inoue K., Furihata M., Ohtsuki Y., Fujita Y. Distribution of S-100 protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis. Virchows Arch A Pathol Anat Histopathol. 1993;422(5):351–355. doi: 10.1007/BF01605452. [DOI] [PubMed] [Google Scholar]
  19. Johnson J. G., Jenkins M. K. Co-stimulatory functions of antigen-presenting cells. J Invest Dermatol. 1992 Nov;99(5):62S–65S. doi: 10.1111/1523-1747.ep12669010. [DOI] [PubMed] [Google Scholar]
  20. June C. H., Bluestone J. A., Nadler L. M., Thompson C. B. The B7 and CD28 receptor families. Immunol Today. 1994 Jul;15(7):321–331. doi: 10.1016/0167-5699(94)90080-9. [DOI] [PubMed] [Google Scholar]
  21. Kato H., Mizuno N., Nakagawa K., Furukawa M., Hamada T. Microcystic adnexal carcinoma: a light microscopic, immunohistochemical and ultrastructural study. J Cutan Pathol. 1990 Apr;17(2):87–95. doi: 10.1111/j.1600-0560.1990.tb00062.x. [DOI] [PubMed] [Google Scholar]
  22. Kondo K., Mukai K., Sato Y., Matsuno Y., Shimosato Y., Monden Y. An immunohistochemical study of thymic epithelial tumors. III. The distribution of interdigitating reticulum cells and S-100 beta-positive small lymphocytes. Am J Surg Pathol. 1990 Dec;14(12):1139–1147. [PubMed] [Google Scholar]
  23. Kradin R. L., Xia W., Pike M., Byers H. R., Pinto C. Interleukin-2 promotes the motility of dendritic cells and their accumulation in lung and skin. Pathobiology. 1996;64(4):180–186. doi: 10.1159/000164033. [DOI] [PubMed] [Google Scholar]
  24. Krenács L., Tiszalvicz L., Krenács T., Boumsell L. Immunohistochemical detection of CD1A antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody 010. J Pathol. 1993 Oct;171(2):99–104. doi: 10.1002/path.1711710206. [DOI] [PubMed] [Google Scholar]
  25. Lotze M. T., Shurin M., Davis I., Amoscato A., Storkus W. J. Dendritic cell based therapy of cancer. Adv Exp Med Biol. 1997;417:551–569. doi: 10.1007/978-1-4757-9966-8_91. [DOI] [PubMed] [Google Scholar]
  26. Makin C. A., Bobrow L. G., Bodmer W. F. Monoclonal antibody to cytokeratin for use in routine histopathology. J Clin Pathol. 1984 Sep;37(9):975–983. doi: 10.1136/jcp.37.9.975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mommaas M., Mulder A., Vermeer B. J., Koning F. Functional human epidermal Langerhans cells that lack Birbeck granules. J Invest Dermatol. 1994 Dec;103(6):807–810. doi: 10.1111/1523-1747.ep12413456. [DOI] [PubMed] [Google Scholar]
  28. Moulon C., Péguet-Navarro J., Schmitt D. A potential role for CD1a molecules on human epidermal Langerhans cells in allogeneic T-cell activation. J Invest Dermatol. 1991 Sep;97(3):524–528. doi: 10.1111/1523-1747.ep12481556. [DOI] [PubMed] [Google Scholar]
  29. Nakano T., Oka K., Arai T., Morita S., Tsunemoto H. Prognostic significance of Langerhans' cell infiltration in radiation therapy for squamous cell carcinoma of the uterine cervix. Arch Pathol Lab Med. 1989 May;113(5):507–511. [PubMed] [Google Scholar]
  30. Osterhoff B., Rappersberger K., Wang B., Koszik F., Ochiai K., Kinet J. P., Stingl G. Immunomorphologic characterization of Fc epsilon RI-bearing cells within the human dermis. J Invest Dermatol. 1994 Mar;102(3):315–320. doi: 10.1111/1523-1747.ep12371789. [DOI] [PubMed] [Google Scholar]
  31. Porcelli S., Brenner M. B., Greenstein J. L., Balk S. P., Terhorst C., Bleicher P. A. Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature. 1989 Oct 5;341(6241):447–450. doi: 10.1038/341447a0. [DOI] [PubMed] [Google Scholar]
  32. Richters C. D., Hoekstra M. J., van Baare J., Du Pont J. S., Hoefsmit E. C., Kamperdijk E. W. Isolation and characterization of migratory human skin dendritic cells. Clin Exp Immunol. 1994 Nov;98(2):330–336. doi: 10.1111/j.1365-2249.1994.tb06146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rucci L., Bani D., Gallo O., Arbi Riccardi R., Borghi Cirri M. B., Fini-Storchi O. Interdigitating cells in the peritumoral infiltrate of laryngeal carcinomas: an immunocytochemical and ultrastructural study. ORL J Otorhinolaryngol Relat Spec. 1991;53(6):349–356. doi: 10.1159/000276246. [DOI] [PubMed] [Google Scholar]
  34. Schuler G., Romani N. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. Adv Exp Med Biol. 1997;417:7–13. [PubMed] [Google Scholar]
  35. Steinman R. M., Pack M., Inaba K. Dendritic cell development and maturation. Adv Exp Med Biol. 1997;417:1–6. doi: 10.1007/978-1-4757-9966-8_1. [DOI] [PubMed] [Google Scholar]
  36. Strunk D., Egger C., Leitner G., Hanau D., Stingl G. A skin homing molecule defines the langerhans cell progenitor in human peripheral blood. J Exp Med. 1997 Mar 17;185(6):1131–1136. doi: 10.1084/jem.185.6.1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Tsujitani S., Kakeji Y., Watanabe A., Kohnoe S., Maehara Y., Sugimaghi K. Infiltration of S-100 protein positive dendritic cells and peritoneal recurrence in advanced gastric cancer. Int Surg. 1992 Oct-Dec;77(4):238–241. [PubMed] [Google Scholar]
  38. Williams L. A., Egner W., Hart D. N. Isolation and function of human dendritic cells. Int Rev Cytol. 1994;153:41–103. doi: 10.1016/s0074-7696(08)62188-9. [DOI] [PubMed] [Google Scholar]
  39. Yu C. Y., Milstein C. A physical map linking the five CD1 human thymocyte differentiation antigen genes. EMBO J. 1989 Dec 1;8(12):3727–3732. doi: 10.1002/j.1460-2075.1989.tb08548.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES